Opioid Use Disorder Clinical Trial
— Drug DisposalOfficial title:
SafeMedWaste At-Home, Environmentally-Friendly Opioid Disposal Kit for Orthopedic Post-Operative Surgical Patients to Reduce Opioids Available for Diversion
There is an urgent unmet medical need for a cost-effective, environmentally friendly, in-home opioid disposal solution for surgical patients that is clinically proven to reduce opioid use disorder that is substantiated with economic data. SafeMedWaste, Inc. (SMW) has developed the patented SafeMedWaste in-home drug disposal container, that completely destroys opioids within minutes and can be placed in the regular trash, without risk of ground or municipal water contamination. A pilot randomized clinical trial will evaluate the use of SafeMedWaste in 300 adult patients in outpatient surgery clinics undergoing shoulder and knee surgery.
Status | Not yet recruiting |
Enrollment | 300 |
Est. completion date | February 1, 2025 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Inclusion Criteria: - Subject is 18 + years of age - Subject is opioid naive (within the last 3 months), as evidenced by MyChart patient record or response to medical history questions - Subject is scheduled to undergo shoulder and/or knee surgery Exclusion Criteria: - Subject has a history of opioid addiction, as evidenced by MyChart patient record or response to medical history questions - Subject is currently utilizing prescription narcotics for any reason, as evidenced by MyChart patient record or response to medical history questions - Subject does not have the mental capacity to make their own healthcare decisions - Subject is unable to provide written consent |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
SafeMedWaste, Inc. | National Institute on Drug Abuse (NIDA), Prisma Health-Midlands, University of South Carolina |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Reasons for disposal/non- disposal | Reasons why the patient chose to dispose of opioids or chose not to, as reported in the post- surgery survey, will be statistically analyzed and correlated as appropriate to other data. | Within 3 months following surgery | |
Other | Time of disposal | When the patients dispose of opioids, as reported by patients in post-surgery survey and/or documented with pictures in MyChart, will be tracked up to 3 months post-surgery. | Within 3 months following surgery | |
Other | Amount of opioids used | The amount of opioids used will be tracked at visit weeks 2, 6 and 10, post surgery, through clinic pill counts, or as self-reported by patients up to 3 months. | Within 3 months following surgery | |
Other | Opioid Use Disorder (OUD) | Any OUD reported in the patient medical record will be tracked up to 3 months following surgery. | Within 3 months following surgery | |
Other | Diversion event | Any diversion event as described by patient at clinical visit or in post-surgery survey will be recorded. | Within 3 months following surgery | |
Other | Pre-Surgery Survey | Pre-Surgery Survey, see Ex. 1, Protection of Human Subjects, will be completed by patients at enrollment. Questions include patient past surgical experience and attitudes toward pain. Data will be recorded in REDCap and statistically analyzed. | At enrollment | |
Other | Post-Surgery Survey | Patients will answer post-surgery survey, see Ex. 2, Protection of Human Subjects, within 3 months following surgery. Questions include pain experiences from their surgery and disposal compliance. Data will be recorded in REDCAP and statistically analyzed for correlations of patient attitudes toward and experience with pain and other factors to disposal compliance to create clinician/patient education protocols to be studied in future trial. | 3 months following surgery | |
Other | Provider Satisfaction Survey | Provider participants will answer Provider Satisfaction survey, see Ex. 4, Protection of Human Subjects, upon study completion. Data will be recorded in REDCap and statistically analyzed. | Upon study completion | |
Primary | Opioid disposal compliance | Opioid disposal compliance will be tracked up to 3 months post-surgery, as reported by patients in post-surgery survey and/or documented with pictures uploaded by patient to MyChart. | Within 3 months following surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06021431 -
Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT
|
N/A | |
Completed |
NCT06266572 -
Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment
|
Phase 1 | |
Recruiting |
NCT05037682 -
Pain and Opioid Management in Older Adults
|
N/A | |
Completed |
NCT06200740 -
Remotely Observed Methadone Evaluation
|
N/A | |
Not yet recruiting |
NCT06441604 -
Extended-release Buprenorphine as a Novel Low-dose Induction Strategy
|
Phase 2 | |
Recruiting |
NCT06028126 -
Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial
|
N/A | |
Completed |
NCT02559973 -
Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
|
Phase 1 | |
Completed |
NCT02593474 -
Medication-Assisted Treatment for Youth With Substance Use Disorders
|
Phase 1 | |
Completed |
NCT02440256 -
Expanded HIV Care in Opioid Substitution Treatment (EHOST) Trial
|
N/A | |
Completed |
NCT05587998 -
A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.
|
Phase 1 | |
Terminated |
NCT04577144 -
An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery - Long Term
|
||
Recruiting |
NCT06001437 -
Following Outcomes Remotely Within Addiction Recovery Domains
|
||
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 | |
Completed |
NCT05546229 -
Assessment of Methadone and Buprenorphine in Interstitial Fluid
|
||
Not yet recruiting |
NCT06104280 -
Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment
|
N/A | |
Not yet recruiting |
NCT06416020 -
Integrating MOUD in African American Community Settings (Better Together)
|
N/A | |
Recruiting |
NCT06206291 -
Cannabidiol for Opioid Addiction
|
Phase 2 | |
Completed |
NCT05552040 -
START NOW in the Treatment of Opioid Addicted Individuals
|
N/A | |
Recruiting |
NCT05459922 -
Adjunctive Bright Light Therapy for Opioid Use Disorder
|
N/A | |
Recruiting |
NCT05343169 -
Community-based Education, Navigation, and Support Intervention for Military Veterans
|
N/A |